Companies / Minerva Neurosciences, Inc.

Minerva Neurosciences, Inc.

Nasdaq: NERVCIK 1598646BURLINGTON, MAminervaneurosciences.com

Financials · FY2024

Revenue$0
Net income$-293.42M
Total debt$9.55M
Cash$24.65M
Diluted EPS$-34.67
Shares outstanding47.7M

Ownership

47.7M shares outstanding · as of Aug 4, 2026
70.3%Institutions
Ownership
Institutions70.25%33,545,007
Public float29.75%14,202,552

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 2

View all →
Insider% of sharesShares

Institutional holders 34

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 3, 2026Hasler Hans Peter
Director
GrantStock Option (right to buy)+50K
50,000
0.10% of shares
low
Jun 3, 2026Van Heek G Jan
Director
GrantStock Option (right to buy)+50K
50,000
0.10% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Farallon Capital Partners, L.P.Passive13G/A
Balyasny Asset Management L.P.Passive13G
Adage Capital Management, L.P.Passive13G
Logos Global Management LPPassive13G
Coastlands Capital LPPassive13G
Balyasny Asset Management L.P.Passive13G/A
Janus Henderson Group PLCPassive13G

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
NERV603380205